Safety and dosimetry evaluation of personalized dose I131-apamistamab prior to HCT in the phase 3 SIERRA trial for patients with relapsed/refractory acute myeloid leukemia (R/R AML) Meeting Abstract
| Authors: | Pandit-Taskar, N.; Natwa, M.; Chen, M.; Yap, W.; Wiseman, G.; Leung, E.; Desai, A.; Brodin, P.; Haeuber, E.; Nahar, A.; Wahl, R. L. |
| Abstract Title: | Safety and dosimetry evaluation of personalized dose I131-apamistamab prior to HCT in the phase 3 SIERRA trial for patients with relapsed/refractory acute myeloid leukemia (R/R AML) |
| Meeting Title: | 2023 Annual Congress of the European Association of Nuclear Medicine (EANM'23) |
| Journal Title: | European Journal of Nuclear Medicine and Molecular Imaging |
| Volume: | 50 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Sep 9-13 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 1619-7070 |
| Publisher: | Springer |
| Date Published: | 2023-09-01 |
| Start Page: | S93 |
| Language: | English |
| ACCESSION: | WOS:001084059700191 |
| PROVIDER: | wos |
| DOI: | 10.1007/s00259-023-06333-x |
| PUBMED: | 37594496 |
| Notes: | Meeting Abstract: OP-193 -- Source: Wos |
